The Pharmaceutical Forum was set up in 2005 as a three-year process, in order to find relevant solutions to public health considerations regarding pharmaceuticals, while ensuring the competitiveness of the industry and the sustainability of the national health care systems.
This high-level ministerial platform for discussion between Member States, EU institutions, industry, health care professionals, patients and insurance funds focused its work on three main topics: information to patients on diseases and treatment options; pricing and reimbursement policy and relative effectiveness.
The last Ministerial meeting, on 2 October 2008, concluded the three-year exercise with the adoption of the final report gathering Final Conclusions and Recommendations [67 KB] . It also included all technical documents and projects developed by the three working groups to support implementing actions addressed to the European Commission, Member States and interested stakeholders. The Pharmaceutical Forum led to a transparent exchange of views and the creation of European principles and methodologies on information to patients, pricing policy and relative effectiveness.
The Forum itself is a follow-up to the High Level Group on Innovation and Provision of Medicines, called the "G-10 Initiative".
- Pharmaceutical Forum - The three years process
- Pharmaceutical Forum - Working group on Pricing and Reimbursement, Information to patients, Relative effectiveness
- Final conclusions and recommendations of the Pharmaceutical Forum (brochure) [3 MB]
- G10 Medicines - High Level Group on innovation and the Provision of Medicines